Amgen Inc. Revenue 2007–2025
Amgen Inc. reported $36.75B of revenue for fiscal 2025. That was 10.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +44.6%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $36.75B | +10.0% |
| FY 2024 | $33.42B | +18.6% |
| FY 2023 | $28.19B | +7.1% |
| FY 2022 | $26.32B | +1.3% |
| FY 2021 | $25.98B | +2.2% |
| FY 2020 | $25.42B | +8.8% |
| FY 2019 | $23.36B | -1.6% |
| FY 2018 | $23.75B | +3.9% |
| FY 2017 | $22.85B | -0.6% |
| FY 2016 | $22.99B | +6.1% |
| FY 2015 | $21.66B | +8.0% |
| FY 2014 | $20.06B | +7.4% |
| FY 2013 | $18.68B | +8.2% |
| FY 2012 | $17.27B | +10.8% |
| FY 2011 | $15.58B | +3.5% |
| FY 2010 | $15.05B | +2.8% |
| FY 2009 | $14.64B | -2.4% |
| FY 2008 | $15.00B | +1.6% |
| FY 2007 | $14.77B | — |
Source: Amgen Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AMGN 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Amgen Inc. reported $36.75B of revenue for fiscal 2025. That was 10.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +44.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Amgen Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmgen Inc. — frequently asked questions
What is Amgen Inc.'s revenue?
Amgen Inc. (AMGN) reported revenue of $36.75B for fiscal year 2025, per its SEC filings.
How has Amgen Inc.'s revenue changed over time?
Between fiscal 2007 and 2025, AMGN's revenue grew at roughly 5.2% per year (compound annual rate), from $14.77B to $36.75B.
Where does this data come from?
Figures are computed from Amgen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.